生物科技-跨越分子：为何 2026 年是 AI 药物研发的决胜之年-Biotechnology-Crossing the Molecule Why 2026 Is the Make-or-Break Year for AI in Drug Discovery

February 2, 2026 11:31 PM GMT Biotechnology | Asia Pacific M Idea Crossing the Molecule: Why 2026 Is the Make-or-Break Year for AI in Drug Discovery AI-driven drug discovery is verging on an inflection, as serial data readouts in 2026 test whether biology models can meaningfully improve drug development success rates. We lay out what could shift AIDD from workflow tool to industry adoption curve, and how investors should position accordingly. AIDD has moved from pilot wins to commercial reality: Chemistry-f ...